首页|活心丸联合常规西药治疗冠心病心绞痛患者的效果

活心丸联合常规西药治疗冠心病心绞痛患者的效果

扫码查看
目的:观察活心丸联合常规西药治疗冠心病心绞痛患者的效果.方法:选取2022年12月至2023年12月该院收治的70例冠心病心绞痛患者进行前瞻性研究,按随机数字表法将其分为研究组与对照组各35例.对照组采用常规西药治疗,研究组在对照组基础上联合活心丸治疗,比较两组临床疗效,治疗前后心功能指标[左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、左心室射血分数(LVEF)]水平、血管内皮功能指标[内皮素-1(ET-1)、一氧化氮(NO)]水平、心肌损伤标志物[基质金属蛋白酶-9(MMP-9)、可溶性细胞间黏附分子-1(sICAM-1)]水平、临床症状(心绞痛发作持续时间、心绞痛发作次数)、中医证候积分,以及不良反应发生率.结果:研究组治疗总有效率为91.43%(32/35),高于对照组的68.57%(24/35),差异有统计学意义(P<0.05);两组LVESD、LVEDD水平均低于治疗前,且研究组低于对照组,两组LVEF水平均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组ET-1水平均低于治疗前,且研究组低于对照组,两组NO水平均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组MMP-9、sICAM-1水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组心绞痛发作持续时间均短于治疗前,且研究组短于对照组,两组心绞痛发作频率均少于治疗前,且研究组少于对照组,差异有统计学意义(P<0.05);两组面肢浮肿、神疲气短、胸闷心痛等中医证候积分均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:活心丸联合常规西药治疗冠心病心绞痛患者可提高治疗总有效率,改善心功能指标和血管内皮功能指标水平,缓解临床症状,降低中医证候积分和心肌损伤标志物水平的效果优于单纯常规西药治疗.
Effects of Huoxin pills combined with conventional Western medicine in treatment of patients with coronary heart disease angina pectoris
Objective:To observe effects of Huoxin pills combined with conventional Western medicine in treatment of patients with coronary heart disease angina pectoris. Methods:A prospective study was conducted on 70 patients with coronary heart disease angina pectoris admitted to this hospital from December 2022 to December 2023. According to the random number table method,they were divided into study group and control group,35 cases in each group. The control group was treated with conventional Western medicine,while the study group was treated with Huoxin pills on the basis of that of the control group. The clinical efficacy,the cardiac function indexes[left ventricular end-diastolic diameter (LVEDD),left ventricular end-systolic diameter (LVESD),left ventricular ejection fraction (LVEF)]levels,the vascular endothelial function indexes[endothelin-1 (ET-1),nitric oxide (NO)]levels,the myocardial injury markers[matrix metalloproteinase-9 (MMP-9),soluble intercellular adhesion molecule-1 (sICAM-1)]levels,the clinical symptoms (duration of angina pectoris,number of angina pectoris attacks),and the TCM syndrome score before and after the treatment,and the incidence of adverse reactions were compared between the two groups. Results:The total effective rate of the study group was 91.43% (32/35),which was higher than 68.57% (24/35) of the control group,and the difference was statistically significant (P<0.05). The levels of LVESD and LVEDD in the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;the LVEF levels of the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;and the differences were statistically significant (P<0.05). The levels of ET-1 in the two groups were lower than those before the treatment,and that in the study group was lower than that in the control group;the NO levels of the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;and the differences were statistically significant (P<0.05). The levels of MMP-9 and sICAM-1 in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant (P<0.05). The duration of angina pectoris in the two groups was shorter than that before the treatment,and that in the study group was shorter than that in the control group;the number of angina pectoris attacks in the two groups was less than that before the treatment,and that in the study group was less than that in the control group;and the differences were statistically significant (P<0.05). The scores of TCM syndromes such as facial edema,mental fatigue and shortness of breath,chest tightness and heartache in the two groups were lower than those before the treatment,that in the study group was lower than that in the control group,and the differences were statistically significant (P<0.05). However,there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusions:Huoxin pills combined with conventional Western medicine can improve the total effective rate of treatment,improve the levels of cardiac function indexes and vascular endothelial function indexes,relieve the clinical symptoms,reduce the TCM syndrome scores and the levels of myocardial injury markers in the patients with coronary heart disease and angina pectoris. Moreover,it is superior to simple conventional Western medicine treatment.

Huoxin pillsCoronary heart isease angina pectorisCardiac functionTCM syndromeMyocardial injury markerVascular endothelial functionAdverse reaction

陶锴、廖娟

展开 >

高安市人民医院,心血管内科,江西 高安 330800

高安市人民医院,内科,江西 高安 330800

活心丸 冠心病心绞痛 心功能 中医证候 心肌损伤标志物 血管内皮功能 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(23)